Quick Overview: In today's episode of the Psychedelic Therapy Frontiers podcast Abby and Patrick continue their series on psychedelics via an in-depth interview with MindMed is a clinical-stage US biopharmaceutical company aiming to leverage psychedelic medicines to target life-debilitating ...
Dan Karlin Md Cmo Definium - Detailed Overview & Context
In today's episode of the Psychedelic Therapy Frontiers podcast Abby and Patrick continue their series on psychedelics via an in-depth interview with MindMed is a clinical-stage US biopharmaceutical company aiming to leverage psychedelic medicines to target life-debilitating ... Show Notes DON'T MISS THIS EPISODE! Our fascinating guest today is a game-changer in progressive psychiatric treatments to ... In this week's episode of Healthspan Academy, I had a fascinating chat with MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders.
Investing in Psychedelics a Conversation with MindMed Featuring: Rob Barrow, Chief Executive Officer &
